This is an archival story that predates current editorial management.
This archival content was written, edited, and published prior to LAist's acquisition by its current owner, Southern California Public Radio ("SCPR"). Content, such as language choice and subject matter, in archival articles therefore may not align with SCPR's current editorial standards. To learn more about those standards and why we make this distinction, please click here.
Local researchers at the Saban Research Institute of Children's Hospital Los Angeles may have found a new treatment for acute lymphoblastic leukemia (ALL), a type of cancer that affects white blood cells.
According to a statement from the hospital, the leading cause of relapse among people with ALL is that the cancer becomes resistant to chemo. This new treatment, developed by Drs. Nora Heisterkamp and Reshmi Parameswaran, binds only to cancer cells, meaning that in addition to addressing cancers that have become resistant to other drugs, the treatment is far less damaging to the body as a whole.
ALL is the most common type of cancer that's diagnosed in children.
